GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Down 12.0% in October

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 21,300 shares, a decline of 12.0% from the September 30th total of 24,200 shares. Currently, 0.7% of the shares of the company are sold short. Based on an average trading volume of 15,600 shares, the short-interest ratio is presently 1.4 days.

GlucoTrack Stock Performance

NASDAQ GCTK traded down $0.11 on Thursday, reaching $1.68. 11,064 shares of the company’s stock traded hands, compared to its average volume of 24,998. GlucoTrack has a fifty-two week low of $0.66 and a fifty-two week high of $4.95. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.12 and a current ratio of 0.12. The firm has a market cap of $9.20 million, a price-to-earnings ratio of -0.69 and a beta of 0.13. The stock has a 50 day moving average price of $2.40 and a 200-day moving average price of $2.24.

GlucoTrack (NASDAQ:GCTK) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($0.82) earnings per share for the quarter.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.